Lijun Huang

1 ta ish

Sun Yat-sen University

1. Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer

   Dongbing Ding, Rongpu Liang, Tan Li +12

   Maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.331972